HMOX1 and breast carcinoma: Gandini et al. reported that HO-1 overexpression reduced the tumor burden in two different murine models (syngeneic and xenograft) of breast cancer development and that positive expression of HO-1 was associated with longer overall survival of patients with breast cancer [68].